Company intelligence / Profile preview

Moolec Science

Luxembourg, Luxembourg (province), Luxembourg

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Moolec has achieved field, regulatory, and commercial scale for molecularly farmed products (e.g., Piggy Sooy™ with porcine myoglobin in soybean, GLASO™ with high GLA in safflower oil). Piggy Sooy™ is progressing through FDA regulatory consultation and was the first molecular farming crop approved by USDA-APHIS for open field trials in the US[4][8].

Therapeutic areas: OtherMetabolic Disorders
Modalities: Recombinant proteinGene-engineered crop ingredientMolecular farming
Industry: Agriculture & AgTech

Partnerships

Major partnerships with Bioceres GroupNutrecon LLCGentle Techcommercial offtake agreements with global CPG companytechnology/formulation partnerships likely in food ingredient sector

Beyond the preview

Go deeper on Moolec Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Moolec Science.

Explore the full profile